E01P0061 Human Pulmonary Activation Regulated Chemokine ELISA kit
The Human Pulmonary Activation Regulated Chemokine ELISA kit can be used to identify samples from the human species. Pulmonary Activation Regulated Chemokine can also be called CCL18, AMAC1, SCYA18, DCCK1, MIP-4, CKb7, Alternative Macrophage Activation Associated CC Chemokine 1, Chemokine C-C-Motif Ligand 18, Macrophage inflammatory protein 4.
Product Information | |
Cat. No. | E01P0061 |
Product Name | Human Pulmonary Activation Regulated Chemokine ELISA kit |
Species | Human |
Product Size | 48 Tests / 96 Tests |
Concentration | 5.0-100 ng/ml |
Sensitivity | 1.0 ng/ml |
Principal | Competitive ELISA |
Sample Volume | 100 ul |
Sample Type | Serum, plasma, cell culture supernatants, body fluid and tissue homogenate |
Assay Time | 90 minutes |
Platform | Microplate Reader |
Conjugate | HRP |
Detection Method | Colorimetric |
Storage | 2-8°C |
Kit Components | ||
MATERIALS | SPECIFICATION | QUANTITY |
MICROTITER PLATE | 96 wells | stripwell |
ENZYME CONJUGATE | 6.0 mL | 1 vial |
STANDARD A (0.5mL) | 0 ng/mL | 1 vial |
STANDARD B (0.5mL) | 5.0 ng/mL | 1 vial |
STANDARD C (0.5mL) | 10 ng/mL | 1 vial |
STANDARD D (0.5mL) | 25 ng/mL | 1 vial |
STANDARD E (0.5mL) | 50 ng/mL | 1 vial |
STANDARD F (0.5mL) | 100 ng/mL | 1 vial |
SUBSTRATE A | 6 mL | 1 vial |
SUBSTRATE B | 6 mL | 1 vial |
STOP SOLUTION | 6 mL | 1 vial |
WASH SOLUTION (100 x) | 10 mL | 1 vial |
BALANCE SOLUTION | 3 mL | 1 vial |
Principle of the Assay |
PARC ELISA kit uses an anti-PARC antibody and an PARC-HRP conjugate in a competitive enzyme immunoassay method. PARC-HRP conjugate is incubated with the assay sample and buffer in a pre-coated plate for one hour. The wells are decanted and washed five times when the incubation period is over. The HRP enzyme substrate is then incubated in the wells. The result of the enzyme-substrate reaction is a complex that is blue in hue. The process is finally stopped by adding a stop solution, causing the solution to turn yellow. In a microplate reader, the color intensity is measured spectrophotometrically at 450 nm. Due to competition for the anti-PARC antibody binding site between PARC from samples and PARC-HRP conjugate, the intensity of the color is inversely proportional to the concentration of PARC. Since the number of sites is limited, as more sites are occupied by PARC from the sample, fewer sites are left to bind PARC-HRP conjugate. A standard curve is plotted relating the intensity of the color (O.D.) to the concentration of standards. The PARC concentration in each sample is interpolated from this standard curve. |
Coefficient of Variance | Intra Variation% ＜10% | |
Inter Variation% ＜12% | ||
Recovery | 95-102% | |
Linearity | Diluent Ratio | Range % |
1:2 | 93-105 | |
1:4 | 88-106 | |
1:8 | 86-108 | |
Specificity/Cross-reactivity | No significant cross-reactivity or interference between PARC and analogues was observed. | |
E01P0061 has been referenced in the below publications：
The expression level and value of CCL-18 in the serum of the patients with Chronic Obstructive Pulmonary Disease.
Related Bluegene Biotech Products
BlueGene Biotech News
